Cross-susceptibility among tetracyclines in Gram-positive infections: microbiological basis, EUCAST/CLSI guidance and clinical implications for doxycycline use

Francisco Javier Candel, Mayra Matesanz, Ana Muñoz-Gómez, Jose L Del Pozo

Open source

DOI
10.1093/jac/dkag353
Published
2026-10-06
Container
Journal of Antimicrobial Chemotherapy
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkag353,
  title = {Cross-susceptibility among tetracyclines in Gram-positive infections: microbiological basis, EUCAST/CLSI guidance and clinical implications for doxycycline use},
  author = {Francisco Javier Candel and Mayra Matesanz and Ana Muñoz-Gómez and Jose L Del Pozo},
  year = {2026},
  journal = {Journal of Antimicrobial Chemotherapy},
  doi = {10.1093/jac/dkag353},
  url = {https://doi.org/10.1093/jac/dkag353}
}

RIS

TY  - JOUR
TI  - Cross-susceptibility among tetracyclines in Gram-positive infections: microbiological basis, EUCAST/CLSI guidance and clinical implications for doxycycline use
AU  - Francisco Javier Candel
AU  - Mayra Matesanz
AU  - Ana Muñoz-Gómez
AU  - Jose L Del Pozo
PY  - 2026
JO  - Journal of Antimicrobial Chemotherapy
DO  - 10.1093/jac/dkag353
UR  - https://doi.org/10.1093/jac/dkag353
ER  - 

APA

Candel, F. J., Matesanz, M., Muñoz-Gómez, A., & Pozo, J. L. D. (2026). Cross-susceptibility among tetracyclines in Gram-positive infections: microbiological basis, EUCAST/CLSI guidance and clinical implications for doxycycline use. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag353

Source records